145 related articles for article (PubMed ID: 38647728)
1. Predicting contralateral extraprostatic extension in unilateral high-risk prostate cancer: a multicentric external validation study.
Diamand R; Roche JB; Lacetera V; Simone G; Windisch O; Benamran D; Fourcade A; Fournier G; Fiard G; Ploussard G; Roumeguère T; Peltier A; Albisinni S
World J Urol; 2024 Apr; 42(1):247. PubMed ID: 38647728
[TBL] [Abstract][Full Text] [Related]
2. External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R; Roche JB; Lievore E; Lacetera V; Chiacchio G; Beatrici V; Mastroianni R; Simone G; Windisch O; Benamran D; Favre MM; Fourcade A; Nguyen TA; Fournier G; Fiard G; Ploussard G; Roumeguère T; Peltier A; Albisinni S
Eur Urol Focus; 2023 Mar; 9(2):309-316. PubMed ID: 36153227
[TBL] [Abstract][Full Text] [Related]
3. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
[TBL] [Abstract][Full Text] [Related]
4. Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy.
Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde H; Stomps S; Schoots IG; Biesma DH; Witjes JA; van Basten JA
Eur Urol Oncol; 2022 Jun; 5(3):328-337. PubMed ID: 32972895
[TBL] [Abstract][Full Text] [Related]
5. An Algorithm to Personalize Nerve Sparing in Men with Unilateral High-Risk Prostate Cancer.
Martini A; Soeterik TFW; Haverdings H; Rahota RG; Checcucci E; De Cillis S; Hermanns T; Fankhauser CD; Afferi L; Moschini M; Mattei A; Kesch C; Heidegger I; Preisser F; Zattoni F; Marquis A; Marra G; Gontero P; Briganti A; Montorsi F; Porpiglia F; Van Basten JP; Van den Bergh RCN; Van Melick HHE; Ploussard G; Gandaglia G; Valerio M
J Urol; 2022 Feb; 207(2):350-357. PubMed ID: 34547922
[TBL] [Abstract][Full Text] [Related]
6. External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Diamand R; Ploussard G; Roumiguié M; Oderda M; Benamran D; Fiard G; Quackels T; Assenmacher G; Simone G; Van Damme J; Malavaud B; Iselin C; Descotes JL; Roche JB; Peltier A; Roumeguère T; Albisinni S
Eur Urol; 2021 Feb; 79(2):180-185. PubMed ID: 33023770
[TBL] [Abstract][Full Text] [Related]
7. External validation of the Martini nomogram for prediction of side-specific extraprostatic extension of prostate cancer in patients undergoing robot-assisted radical prostatectomy.
Soeterik TFW; van Melick HHE; Dijksman LM; Küsters-Vandevelde HVN; Biesma DH; Witjes JA; van Basten JA
Urol Oncol; 2020 May; 38(5):372-378. PubMed ID: 32088104
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer.
Somford DM; Hamoen EH; Fütterer JJ; van Basten JP; Hulsbergen-van de Kaa CA; Vreuls W; van Oort IM; Vergunst H; Kiemeney LA; Barentsz JO; Witjes JA
J Urol; 2013 Nov; 190(5):1728-34. PubMed ID: 23680307
[TBL] [Abstract][Full Text] [Related]
9. Comparison of MRI-Based Staging and Pathologic Staging for Predicting Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.
Merriman KM; Harmon SA; Belue MJ; Yilmaz EC; Blake Z; Lay NS; Phelps TE; Merino MJ; Parnes HL; Law YM; Gurram S; Wood BJ; Choyke PL; Pinto PA; Turkbey B
AJR Am J Roentgenol; 2023 Dec; 221(6):773-787. PubMed ID: 37404084
[No Abstract] [Full Text] [Related]
10. External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.
Heetman JG; van der Hoeven EJRJ; Rajwa P; Zattoni F; Kesch C; Shariat S; Dal Moro F; Novara G; La Bombara G; Sattin F; von Ostau N; Pötsch N; Baltzer PAT; Wever L; Van Basten JPA; Van Melick HHE; Van den Bergh RCN; Gandaglia G; Soeterik TFW;
Prostate Cancer Prostatic Dis; 2023 Nov; ():. PubMed ID: 37932522
[TBL] [Abstract][Full Text] [Related]
11. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy.
Gandaglia G; Ploussard G; Valerio M; Mattei A; Fiori C; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Moschini M; Zamboni S; Rakauskas A; Tian Z; Karakiewicz PI; De Cobelli F; Porpiglia F; Montorsi F; Briganti A
Eur Urol; 2020 Jun; 77(6):733-741. PubMed ID: 31547938
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the extent of extraprostatic extension and survival following radical prostatectomy.
Jeong BC; Chalfin HJ; Lee SB; Feng Z; Epstein JI; Trock BJ; Partin AW; Humphreys E; Walsh PC; Han M
Eur Urol; 2015 Feb; 67(2):342-6. PubMed ID: 24968968
[TBL] [Abstract][Full Text] [Related]
13. Low PI-RADS assessment category excludes extraprostatic extension (≥pT3a) of prostate cancer: a histology-validated study including 301 operated patients.
Alessi S; Pricolo P; Summers P; Femia M; Tagliabue E; Renne G; Bianchi R; Musi G; De Cobelli O; Jereczek-Fossa BA; Bellomi M; Petralia G
Eur Radiol; 2019 Oct; 29(10):5478-5487. PubMed ID: 30887199
[TBL] [Abstract][Full Text] [Related]
14. How Can We Identify Extraprostatic Extension (EPE) Before Surgery? The Use of a Preoperative Prostate MRI EPE Scoring System to Assess Postprostatectomy Locally Advanced Prostate Cancer.
Bansal U; Estevez A; Black J; Williamson T; Kaul S; Crociani C; Sun J; Tsai LL; Mechaber-Di Fiori J; Gershman B; Chang P; Wagner AA
J Endourol; 2024 May; 38(5):499-504. PubMed ID: 38326749
[No Abstract] [Full Text] [Related]
15. Prediction of extraprostatic extension on multi-parametric magnetic resonance imaging in patients with anterior prostate cancer.
Ahn H; Hwang SI; Lee HJ; Suh HS; Choe G; Byun SS; Hong SK; Lee S; Lee J
Eur Radiol; 2020 Jan; 30(1):26-37. PubMed ID: 31385046
[TBL] [Abstract][Full Text] [Related]
16. A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy.
Heetman JG; Soeterik TFW; Wever L; Meyer AR; Nuininga JE; van Soest RJ; van Melick HHE; van Basten JPA; van den Bergh RCN
World J Urol; 2022 Dec; 40(12):2919-2924. PubMed ID: 36344738
[TBL] [Abstract][Full Text] [Related]
17. Transperineal template saturation and conventional biopsy for stage prediction in prostate cancer.
Lehner F; Crippa A; Sigg S; Eberli D; Mortezavi A
BJU Int; 2023 Dec; 132(6):696-704. PubMed ID: 37704215
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy.
Gandaglia G; Ploussard G; Valerio M; Marra G; Moschini M; Martini A; Roumiguié M; Fossati N; Stabile A; Beauval JB; Malavaud B; Scuderi S; Barletta F; Afferi L; Rakauskas A; Gontero P; Mattei A; Montorsi F; Briganti A
Eur Urol Oncol; 2020 Dec; 3(6):739-747. PubMed ID: 32847747
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.
Radtke JP; Hadaschik BA; Wolf MB; Freitag MT; Schwab C; Alt C; Roth W; Duensing S; Pahernik SA; Roethke MC; Schlemmer HP; Hohenfellner M; Teber D
J Endourol; 2015 Dec; 29(12):1396-405. PubMed ID: 26154571
[TBL] [Abstract][Full Text] [Related]
20. Extraprostatic Extension in Core Biopsies Epitomizes High-risk but Locally Treatable Prostate Cancer.
Goldberg H; Ramiz AH; Glicksman R; Salgado NS; Chandrasekar T; Klaassen Z; Wallis CJD; Hosni A; Moraes FY; Ghai S; Kulkarni GS; Hamilton RJ; Perlis N; Toi A; Chung P; Evans A; van der Kwast T; Finelli A; Fleshner N; Berlin A
Eur Urol Oncol; 2019 Feb; 2(1):88-96. PubMed ID: 30929849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
